Latest news, Events and Press Releases

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to communications@curiumpharma.com

News Press releases Events Publications

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 177Lu-PSMA-I&T for Prostate Cancer in Japan

4th February 2026

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

7th January 2026

Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland

23rd December 2025

Curium Establishes Legal Entity in China

3rd December 2025

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

20th November 2025

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

17th November 2025

Curium Announces First Commercial Doses of diagnostic radiopharmaceuticals in Czech Republic and Slovakia for Patients with Prostate Cancer

6th November 2025

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

15th October 2025

Newcastle & Oxford Set To Benefit From New Technology to Diagnose Disease

8th October 2025

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

21st May 2025

Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer

12th May 2025

Curium enhances its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

10th April 2025

1 2 3 … 5